Sasaki M, Maeda A, Fujimura A
Department of Medicine, Sarufutsumura Hospital, Hokkaido, Japan.
Eur J Clin Pharmacol. 1998 Jun;54(4):299-302. doi: 10.1007/s002280050463.
The Effect of omeprazole, a proton pump inhibitor, and cimetidine, and H 2-receptor antagonist, on plasma aldosterone (PA) response to angiotensin II (AII) were evaluated.
Furosemide (a loop diuretic agent, 20 mg) was given intravenously to eight healthy subjects during a control period, and after pretreatment with omeprazole (20 mg daily) or cimetidine (800 mg daily) for 6 days. Blood samples for determination of plasma renin activity (PRA), AII, PA, adrenotorticotropic hormone (ACTH) and potassium were obtained just before, and 30, 60 min and 120 min after furosemide administration.
PRA, AII and PA increased significantly after furosemide administration whereas ACTH and potassium did not. Significant correlations between plasma AII and PA were obtained in the control and omeprazole trial, but not in the cimetidine trial. The slope of the regression lines of the control and omeprazole trails did not differ significantly.
These results suggest that, in contrast to cimetidine, the inhibitory effect of omeprazole on AII-stimulated aldosterone production following dosing with furosemide is negligible.
评估质子泵抑制剂奥美拉唑和H2受体拮抗剂西咪替丁对血浆醛固酮(PA)对血管紧张素II(AII)反应的影响。
在对照期,以及用奥美拉唑(每日20mg)或西咪替丁(每日800mg)预处理6天后,对8名健康受试者静脉注射速尿(一种袢利尿剂,20mg)。在速尿给药前、给药后30、60分钟和120分钟采集血样,用于测定血浆肾素活性(PRA)、AII、PA、促肾上腺皮质激素(ACTH)和钾。
速尿给药后PRA、AII和PA显著升高,而ACTH和钾未升高。在对照试验和奥美拉唑试验中,血浆AII和PA之间存在显著相关性,但在西咪替丁试验中不存在。对照试验和奥美拉唑试验的回归线斜率无显著差异。
这些结果表明,与西咪替丁不同,奥美拉唑对速尿给药后AII刺激的醛固酮生成的抑制作用可忽略不计。